Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution Multi-Sector ETF (ARKG)

Ark Genomic Revolution Multi-Sector ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 1,017,226,000
  • Market Capitalization, $K 1,017,226
  • Shares Outstanding, K 22,505
  • 60-Month Beta 1.52
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 2.11 (4.55%)
  • Most Recent Dividend 2.108 on 12/27/19
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.85 +19.28%
on 05/01/20
51.16 -9.42%
on 05/26/20
+4.53 (+10.83%)
since 04/29/20
3-Month
24.00 +93.08%
on 03/18/20
51.16 -9.42%
on 05/26/20
+11.95 (+34.75%)
since 02/28/20
52-Week
24.00 +93.08%
on 03/18/20
51.16 -9.42%
on 05/26/20
+16.47 (+55.14%)
since 05/29/19

Most Recent Stories

More News
5 ETFs Up More Than 20% in Three Months

Wall Street has been performing impressively with the major indices climbing to a 12-week high. The rally was mainly powered by optimism over a potential coronavirus vaccine as well as an uptick in the...

SGDM : 29.65 (+2.03%)
IBUY : 64.00 (+2.01%)
ARKG : 46.34 (+2.32%)
WCLD : 35.25 (+4.91%)
URNM : 28.44 (+1.29%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 148.75 (+1.21%)
AZN : 54.60 (+2.06%)
MRNA : 61.50 (+10.73%)
NVAX : 46.04 (+2.68%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
BBH : 160.91 (+2.60%)
FBT : 165.41 (+1.14%)
ARKG : 46.34 (+2.32%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 148.75 (+1.21%)
SNY : 49.11 (+0.88%)
PFE : 38.19 (+0.03%)
MRK : 80.72 (+2.13%)
MRNA : 61.50 (+10.73%)
GSK : 41.92 (+0.91%)
NVAX : 46.04 (+2.68%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
BBH : 160.91 (+2.60%)
BBC : 41.15 (+0.59%)
ARKG : 46.34 (+2.32%)
BNTX : 49.53 (+5.68%)
GNOM : 16.51 (+0.84%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 54.60 (+2.06%)
MRNA : 61.50 (+10.73%)
GSK : 41.92 (+0.91%)
NVAX : 46.04 (+2.68%)
CNCR : 26.49 (+2.75%)
INO : 14.75 (+10.49%)
PTH : 114.10 (+1.46%)
BBC : 41.15 (+0.59%)
BTEC : 41.73 (-0.78%)
ARKG : 46.34 (+2.32%)
IDN : 6.14 (+3.19%)
VXRT : 2.68 (+1.13%)
GNOM : 16.51 (+0.84%)
Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

GSK : 41.92 (+0.91%)
PBE : 58.04 (+1.45%)
ARKG : 46.34 (+2.32%)
GNOM : 16.51 (+0.84%)
IDNA : 35.88 (+1.47%)
First-Mover Pandemic Disease Fight ETF On The Way

Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.

REGN : 612.81 (+5.98%)
GILD : 77.83 (+3.33%)
IMMU : 33.59 (+0.87%)
SBIO : 41.50 (+0.58%)
PBE : 58.04 (+1.45%)
MYOK : 102.29 (+2.14%)
IOVA : 32.09 (-1.75%)
ARKG : 46.34 (+2.32%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 2,442.37 (+1.72%)
GILD : 77.83 (+3.33%)
IBB : 134.74 (+1.82%)
XBI : 103.56 (+0.99%)
IBUY : 64.00 (+2.01%)
BOTZ : 23.18 (-0.26%)
SKYY : 70.70 (+3.33%)
CLIX : 68.62 (+3.95%)
ARKG : 46.34 (+2.32%)
IRBO : 27.64 (+1.43%)
CLOU : 19.95 (+3.31%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 2,442.37 (+1.72%)
GILD : 77.83 (+3.33%)
IBB : 134.74 (+1.82%)
BABA : 207.39 (+3.96%)
XBI : 103.56 (+0.99%)
BBH : 160.91 (+2.60%)
FBT : 165.41 (+1.14%)
IBUY : 64.00 (+2.01%)
BOTZ : 23.18 (-0.26%)
SKYY : 70.70 (+3.33%)
CLIX : 68.62 (+3.95%)
ARKG : 46.34 (+2.32%)
ONLN : 47.21 (+2.97%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 2,442.37 (+1.72%)
GILD : 77.83 (+3.33%)
IBB : 134.74 (+1.82%)
BABA : 207.39 (+3.96%)
XBI : 103.56 (+0.99%)
BBH : 160.91 (+2.60%)
FBT : 165.41 (+1.14%)
IBUY : 64.00 (+2.01%)
BOTZ : 23.18 (-0.26%)
ROBO : 42.59 (-0.37%)
SKYY : 70.70 (+3.33%)
CLIX : 68.62 (+3.95%)
ARKG : 46.34 (+2.32%)
Coronavirus Makes Biotech ETFs Red Hot

The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.

REGN : 612.81 (+5.98%)
PFE : 38.19 (+0.03%)
GILD : 77.83 (+3.33%)
MRNA : 61.50 (+10.73%)
ABT : 94.92 (+3.06%)
AMGN : 229.70 (+2.49%)
TMO : 349.19 (+1.88%)
IBB : 134.74 (+1.82%)
INO : 14.75 (+10.49%)
BBH : 160.91 (+2.60%)
FBT : 165.41 (+1.14%)
ARKG : 46.34 (+2.32%)
IEIH : 29.88 (+1.67%)
BNTX : 49.53 (+5.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ARKG with:

Fund Summary

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology,...

See More

Top 10 Holdings

Name % Holdings
ILLUMINA INC 10,000.00%
Invitae Corp. 10,000.00%
Iovance Biotherapeutics Inc. 10,000.00%
Intellia Therapeutics Inc. 10,000.00%
EDITAS MEDICIN 10,000.00%
CELLECTIS - ADR 10,000.00%
CareDx Inc. 10,000.00%
Twist Bioscience Corp. 10,000.00%
Guardant Health 10,000.00%
Cerus Corp 10,000.00%

See More

Key Turning Points

2nd Resistance Point 47.49
1st Resistance Point 46.91
Last Price 46.34
1st Support Level 45.23
2nd Support Level 44.13

See More

52-Week High 51.16
Last Price 46.34
Fibonacci 61.8% 40.78
Fibonacci 50% 37.58
Fibonacci 38.2% 34.38
52-Week Low 24.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar